Jörn Engelmann

Dr. Jörn Engelmann is a Researcher at the Department of High-field Magnetic Resonance, Max Planck Institute for Biological Cybernetics in Tübingen, Germany. He has held roles including Research Scientist, Lab Manager at the University of Antwerp, and Postdoctoral Research Scientist at the University of Bremen. His research focuses on developing targeted MRI contrast agents, molecular imaging probes, and nanoparticle-based platforms for biomedical applications. Key areas include intracellular targeting of enzymes and mRNA, 19F MRI for non-invasive diagnostics, and receptor-specific imaging in neurobiology.

Education:

• PhD in Chemistry, University of Bremen (1990-1995)
• Diploma in Chemistry, University of Bremen (1984-1990)

Research Interests: Engelmann’s work integrates chemical synthesis, biological evaluation, and advanced MRI techniques. He develops probes for tracking cells in vivo, investigating receptor targeting (e.g., mGluR5, NMDA), and optimizing nanoparticle delivery systems for improved MR contrast. His contributions include dual-modal 1H/19F MRI probes and silica-based platforms enhancing MR sensitivity. Collaborations span institutions like the University of Durham (UK), Hannover Medical School, and the University Hospital Tübingen.

Labs & Teams: He is affiliated with the Department of High-field Magnetic Resonance and previously led the Bio-Imaging Lab at the University of Antwerp.